Mathew P. Martin

2.9k citations

35 papers · 1.6k indexed · h-index 19

Molecular Biology top 10%
Oncology top 5%
Organic Chemistry top 10%
Cell Biology top 5%
Computational Theory and Mathematics top 2%

Co-authors: E. Schönbrunn Gunda I. Georg S.H. Olesen M.E.M. Noble Jane Endicott J. Zhu S. Korolchuk S. Betzi
Topics: Cancer-related Molecular Pathways (12 papers)Microtubule and mitosis dynamics (10 papers)Computational Drug Discovery Methods (6 papers)
Cited by: Oncology Computational Theory and Mathematics Cell Biology
Journals: Nature Communications Cancer Research International Journal of Molecular Sciences
Partner nations: United Kingdom United States France

In The Last Decade

Mathew P. Martin

35 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mathew P. Martin

Since Specialization

Citations

This map shows the geographic impact of Mathew P. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew P. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew P. Martin more than expected).

Fields of papers citing papers by Mathew P. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathew P. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew P. Martin. The network helps show where Mathew P. Martin may publish in the future.

Co-authorship network of co-authors of Mathew P. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Mathew P. Martin. A scholar is included among the top collaborators of Mathew P. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathew P. Martin. Mathew P. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Different applications and differentiated libraries for crystallographic fragment screening 2025 ·Current Opinion in Structural Biology ·(unknown),Mathew P. Martin,Jane Endicott,M.E.M. Noble	1
2	Crystallographic fragment screening of CDK2-cyclin A: FragLites map sites of protein-protein interaction 2025 ·Structure ·(unknown),Mathew P. Martin,Ziwei Jiang,Michael J. Waring,M.E.M. Noble,Jane Endicott,Natalie J. Tatum	1
3	Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding 2025 ·Communications Chemistry ·(unknown),Ayaz Ahmad,Mathew P. Martin,(unknown),(unknown),Lan Z. Wang,(unknown),(unknown),Richard A. Ward,Agnieszka K. Bronowska,M.E.M. Noble,(unknown),Michael J. Waring	1
4	Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy 2023 ·Journal of Medicinal Chemistry ·Duncan C. Miller,Suzannah J. Harnor,Mathew P. Martin,(unknown),Stephen R. Wedge,Céline Cano	15
5	Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome Profiling 2023 ·Journal of Proteome Research ·Amy L. George,(unknown),(unknown),Mathew P. Martin,Matthias Trost,José Luis Marín‐Rubio,María Emilia Dueñas	24
6	Fragment expansion with NUDELs – poised DNA-encoded libraries 2023 ·Chemical Science ·(unknown),(unknown),Jack R. Davison,Mathew P. Martin,Susan J. Tudhope,(unknown),Akane Kawamura,M.E.M. Noble,Stephen R. Wedge,James J. Crawford,Michael J. Waring	8
7	Crystallographic fragment screening in academic cancer drug discovery 2023 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Mathew P. Martin,Jane Endicott,M.E.M. Noble,Natalie J. Tatum	2
8	Conformational study into N-alkyl-N′-aryl ureas to inform drug discovery 2023 ·Bioorganic & Medicinal Chemistry ·Hannah L. Stewart,Marta Bon,Corinne Wills,Mathew P. Martin,Lan Z. Wang,(unknown),Paul G. Waddell,Michael J. Waring	2
9	A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia 2022 ·Journal of Medicinal Chemistry ·José Luis Marín‐Rubio,Rachel E. Heap,María Emilia Dueñas,Tiaan Heunis,(unknown),(unknown),Jonathan Scott,A. John Simpson,Helen J. Blair,Olaf Heidenreich,James M. Allan,(unknown),Mathew P. Martin,Barbara Saxty,Matthias Trost	7
10	Exiting the tunnel of uncertainty: crystal soak to validated hit 2022 ·Acta Crystallographica Section D Structural Biology ·Mathew P. Martin,M.E.M. Noble	4
11	Recent Advances in Kinase Drug Discovery Part I: The Editors’ Take 2021 ·International Journal of Molecular Sciences ·Julie A. Tucker,Mathew P. Martin	2
12	Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach 2018 ·Organic & Biomolecular Chemistry ·Duncan C. Miller,Mathew P. Martin,Santosh Adhikari,(unknown),Jane Endicott,Bernard T. Golding,Ian R. Hardcastle,(unknown),(unknown),Claire Jennings,(unknown),(unknown),Stephen R. Wedge,M.E.M. Noble,Céline Cano	12
13	Structure-based discovery of cyclin-dependent protein kinase inhibitors 2017 ·Essays in Biochemistry ·Mathew P. Martin,Jane Endicott,M.E.M. Noble	42
14	CDK1 structures reveal conserved and unique features of the essential cell cycle CDK 2015 ·Nature Communications ·Nicholas R. Brown,S. Korolchuk,Mathew P. Martin,Will A. Stanley,R. Moukhametzianov,M.E.M. Noble,Jane Endicott	161
15	Identification and Characterization of an Irreversible Inhibitor of CDK2 2015 ·Chemistry & Biology ·(unknown),(unknown),(unknown),Mathew P. Martin,David Staunton,Matthis Geitmann,U. Helena Danielson,Will A. Stanley,Lan Z. Wang,(unknown),Bernard T. Golding,Céline Cano,David R. Newell,M.E.M. Noble,Stephen R. Wedge,Jane Endicott,Roger J. Griffin	95
16	Stability of the Human Hsp90-p50Cdc37 Chaperone Complex against Nucleotides and Hsp90 Inhibitors, and the Influence of Phosphorylation by Casein Kinase 2 2015 ·Molecules ·S.H. Olesen,Donna J. Ingles,Jin-Yi Zhu,Mathew P. Martin,S. Betzi,Gunda I. Georg,Joseph S. Tash,E. Schönbrunn	12
17	Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors 2014 ·ACS Chemical Biology ·S.W. Ember,Jin-Yi Zhu,S.H. Olesen,Mathew P. Martin,Andreas Becker,Norbert Berndt,Gunda I. Georg,E. Schönbrunn	174
18	RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer 2012 ·Cancer Research ·(unknown),(unknown),Roberta Pireddu,Ying Sun,Nan Sun,Mathew P. Martin,E. Schönbrunn,Nicholas J. Lawrence,Saı̈d M. Sebti	123
19	Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2) 2012 ·MedChemComm ·Roberta Pireddu,(unknown),(unknown),Mathew P. Martin,Shen‐Shu Sung,Brian Alexander,J. Zhu,Wayne C. Guida,E. Schönbrunn,Saı̈d M. Sebti,Nicholas J. Lawrence	44
20	A Novel Approach to the Discovery of Small‐Molecule Ligands of CDK2 2012 ·ChemBioChem ·Mathew P. Martin,(unknown),S. Betzi,Donna J. Ingles,J. Zhu,E. Schönbrunn	69

About Mathew P. Martin

Mathew P. Martin is a scholar working on Cell Biology, Oncology and Hematology, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Microtubule and mitosis dynamics (10 papers) and Computational Drug Discovery Methods (6 papers). The work is most often cited by research in Oncology (499 citations), Computational Theory and Mathematics (273 citations) and Cell Biology (277 citations). Mathew P. Martin has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include E. Schönbrunn, Gunda I. Georg, S.H. Olesen, M.E.M. Noble, Jane Endicott, J. Zhu, S. Korolchuk, S. Betzi, Saı̈d M. Sebti and Norbert Berndt. Their work appears in journals such as Nature Communications, Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact